iacs-010759
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 29, 2016 (NCT02882321)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650499 ↗
Also known as
- iacs-010759
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03291938 | Phase 1 | Nov 13, 2017 | University of Texas at Houston |
| NCT02882321 | Phase 1 | Sep 29, 2016 | The Leukemia and Lymphoma Society, University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Texas at Houston | Academic/Hospital | 2 | 2 | 1 | 2016 |
| The Leukemia and Lymphoma Society | Academic/Hospital | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1